DNA Test Spares 2/3 of Breast Cancer Patients Chemotherapy

A groundbreaking gene test can now identify breast cancer patients who can safely skip chemotherapy, sparing two-thirds of people from brutal side effects while maintaining excellent survival rates.

Over 5,000 NHS patients annually could avoid the harsh treatment thanks to this breakthrough.